"On average

The world's first herbal medicine has been created specifically for the treatment of A(H1N1) flu, the Beijing municipal government said at a press conference Thursday.

Related readings:
 China develops herbal medication to treat H1N1 flu
 City's flu vaccine unrelated to US recall
 China reports 116 more deaths from H1N1 flu
 Officials warn of China flu peak in next two months
 
A worker at Dongzhimen traditional medicine hospital measures ingredients for herbal medicine that fights A(H1N1) flu.
According to Wang, daily treatment of the herbal medicine costs 16 yuan,mercurial, with an average total of 80 yuan for complete recovery.
The municipal government has invested 10 million yuan in the project,abercrombie, allowing for city doctors and hospitals to create the herbal cure in only six months.
According to Wang, this was proof of the medicine's effectiveness. However, the medicine was not tested against alternatives already on the market, such as the World Health Organization (WHO) recommended Tamiflu.

This is less than the 197 yuan required for Chinese-made Tamiflu, or 283 yuan for the imported version, as reported by the Beijing Youth Daily in November.
Wang did state however that almost 10 percent of the clinical trial's test subjects were asked by doctors to use additional antibiotics to cure the disease after the herbal medicine failed to do so alone.
The Chinese traditional medicine,abercrombie and fitch france, called Jinhuaqinggan, should be available in hospitals from next year, officials at the conference said.
Wang said clinical tests had been carried out on more than 100 adults less than 70 years of age suffering from A/H1N1 flu, although children weren't included.
Journalists at the conference Thursday questioned whether the testing period was sufficient, noting that western medicines are generally tested for at least one year before being released to the public.
"On average, the test subjects were feverish for 16 hours. This is 10 hours less than those who were untreated in the trials," he said.
Fang Laiying, director of the Beijing health bureau, said they are now just waiting for the green light from the State Food and Drug Administration before releasing it to the public, expected in January.

The medicine will be available in powder and liquid forms.
"This medicine not only targets the virus but also other symptoms caused by the disease," said Wang Chen, director of Beijing Chaoyang Hospital.
Cris Tunon, a representative of the Senior Program Management Office of WHO China,louboutin pas cher, told METRO Thursday that the WHO was looking forward to the clinical use of Jinhuaqinggan.

"The new medicine is an updated version of a recipe we have for fever and cold diseases, and has been around for 2,000 years,abercrombie france," said Liu Qingquan,abercrombie and fitch, director of the Dongzhimen Hospital.
相关的主题文章：


where lead processing occurred.

anyway.Understandably

Related readings